Next Article in Journal
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Next Article in Special Issue
Delivery of Cancer Therapeutics Using Nanotechnology
Previous Article in Journal
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Previous Article in Special Issue
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
 
 
Article

Article Versions Notes

Pharmaceutics 2013, 5(2), 246-260; https://doi.org/10.3390/pharmaceutics5020246
Action Date Notes Link
article pdf uploaded. 23 April 2013 11:49 CEST Version of Record https://www.mdpi.com/1999-4923/5/2/246/pdf
article html file updated 17 June 2015 08:40 CEST Original file -
article html file updated 20 March 2019 21:26 CET Update -
article html file updated 8 May 2019 05:57 CEST Update -
article html file updated 6 February 2020 01:41 CET Update https://www.mdpi.com/1999-4923/5/2/246/html
Back to TopTop